Terms: = Head and neck cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
7929 results:
1. Radioactive iodine refractoriness in Middle Eastern differentiated thyroid cancer: clinical outcome and risk factor analysis.
Parvathareddy SK; Siraj AK; Siraj N; Ahmed SO; Al-Rasheed M; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2024; 15():1326976. PubMed ID: 38812819
[TBL] [Abstract] [Full Text] [Related]
2. The machine learning-based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis.
Zhang X; Zhao X; Jin L; Guo Q; Wei M; Li Z; Niu L; Liu Z; An C
Cancer Med; 2024 Jun; 13(11):e7155. PubMed ID: 38808852
[TBL] [Abstract] [Full Text] [Related]
3. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract] [Full Text] [Related]
4. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic Accuracy of Ultrasound and Fine-Needle Aspiration Cytology in Thyroid Malignancy.
Boudina M; Katsamakas M; Chorti A; Panousis P; Tzitzili E; Tzikos G; Chrisoulidou A; Valeri R; Ioannidis A; Papavramidis T
Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792905
[No Abstract] [Full Text] [Related]
6. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
[TBL] [Abstract] [Full Text] [Related]
7. Enhancing oral squamous cell carcinoma detection: a novel approach using improved EfficientNet architecture.
Soni A; Sethy PK; Dewangan AK; Nanthaamornphong A; Behera SK; Devi B
BMC Oral Health; 2024 May; 24(1):601. PubMed ID: 38783295
[TBL] [Abstract] [Full Text] [Related]
8. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
9. Assessing the Impact of Charged Particle Radiation Therapy for head and neck Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis.
Tan M; Chen Y; Du T; Wang Q; Wu X; Zhang Q; Luo H; Liu Z; Sun S; Yang K; Tian J; Wang X
Technol Cancer Res Treat; 2024; 23():15330338241246653. PubMed ID: 38773763
[No Abstract] [Full Text] [Related]
10. Dynamic radiological features predict pathological response after neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
Ruan Y; Ma Y; Ma M; Liu C; Su D; Guan X; Yang R; Wang H; Li T; Zhou Y; Ma J; Zhang Y
J Transl Med; 2024 May; 22(1):471. PubMed ID: 38762454
[TBL] [Abstract] [Full Text] [Related]
11. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
12. Association between anaesthesia-surgery team sex diversity and major morbidity.
Hallet J; Sutradhar R; Flexman A; McIsaac DI; Carrier FM; Turgeon AF; McCartney C; Chan WC; Coburn N; Eskander A; Jerath A; Perez d'Empaire P; Lorello G
Br J Surg; 2024 May; 111(5):. PubMed ID: 38747328
[TBL] [Abstract] [Full Text] [Related]
13. Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data.
Egebjerg K; Andersen TS; Bæksgaard L; Garbyal R; Siemsen M; Achiam M; Mau-Sørensen PM
Acta Oncol; 2024 May; 63():322-329. PubMed ID: 38745482
[TBL] [Abstract] [Full Text] [Related]
14. Oesophageal cell collection device and biomarker testing to identify high-risk Barrett's patients requiring endoscopic investigation.
Chien S; Glen P; Penman I; Cruickshank N; Bryce G; Crumley A; Phull P; Miller M; Fletcher J; Gunjaca I; Apollos J; Robertson K; Fullarton G
Br J Surg; 2024 May; 111(5):. PubMed ID: 38736137
[TBL] [Abstract] [Full Text] [Related]
15. High incidence of lung cancer death after curative endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
Tajiri A; Tsujii Y; Nishida T; Inoue T; Maekawa A; Kitamura S; Yamaguchi S; Nishihara A; Yamada T; Ogiyama H; Murayama Y; Yamamoto S; Egawa S; Uema R; Yoshihara T; Hayashi Y; Takehara T
Cancer Med; 2024 May; 13(9):e7242. PubMed ID: 38733176
[TBL] [Abstract] [Full Text] [Related]
16. Microsurgical reconstruction for head and neck in patients with end-stage renal disease undergoing dialysis.
Hung CT; Wu MS; Wang CH; Cheng LF; Chou YF; Lee CF; Chen PR; Lee JT
Microsurgery; 2024 May; 44(4):e31186. PubMed ID: 38716649
[TBL] [Abstract] [Full Text] [Related]
17. Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K; Doki Y; Chau I; Xu J; Wyrwicz L; Motoyama S; Ogata T; Kawakami H; Hsu CH; Adenis A; El Hajbi F; Di Bartolomeo M; Braghiroli MI; Holtved E; Makino T; Blum Murphy M; Amaya-Chanaga C; Patel A; Hu N; Matsumura Y; Kitagawa Y; Ajani J
Cancer Med; 2024 May; 13(9):e7235. PubMed ID: 38716626
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
[TBL] [Abstract] [Full Text] [Related]
19. Effect of immune-modulating metronomic capecitabine as an adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma.
He Q; Luo X; Liu L; Zhao C; Li Z; Jin F
BMC Immunol; 2024 May; 25(1):28. PubMed ID: 38710996
[TBL] [Abstract] [Full Text] [Related]
20. N0 neck trial: Does intensification of follow-up (Ultrasound + Physical Examination) influence outcomes in early-stage oral cancer?
Vaish R; Hawaldar R; Gupta S; Dandekar M; Shah S; Chaukar D; Pantvaidya G; Deshmukh A; Chaturvedi P; Pai P; Nair D; Nair S; Thakur M; Ghosh-Laskar S; Agarwal JP; D'Cruz AK
Eur J Cancer; 2024 Jun; 204():114064. PubMed ID: 38705028
[TBL] [Abstract] [Full Text] [Related]
[Next]
